DiaSorin (OTCMKTS:DSRLF) Downgraded by UBS Group to Hold

UBS Group downgraded shares of DiaSorin (OTCMKTS:DSRLF) from a strong-buy rating to a hold rating in a research note published on Tuesday morning,Zacks.com reports.

DiaSorin Stock Performance

Shares of DiaSorin stock opened at $107.88 on Tuesday. The firm’s 50-day simple moving average is $103.07 and its 200-day simple moving average is $103.07. DiaSorin has a twelve month low of $107.88 and a twelve month high of $107.88.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.